Adeno associated viral vector-delivered and hypoxia response element-regulated CD151 expression in ischemic rat heart

Acta Pharmacologica Sinica

Volumn 32, Issue 2, 2011, Pages 201-208

  Wei, Quan ^a   Huang, Xiao Lin ^a   Lin, Jing Yang ^a,b   Fei, Yu Jie ^a   Liu, Zheng Xiang ^a   Zhang, Xin A ^a,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

angiogenesis; cardiac ischemia; CD151; gene expression; gene therapy; hypoxia response element

Indexed keywords

ADENOVIRUS VECTOR; CD151 ANTIGEN; ENOLASE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DRUG EFFICACY; GENE DELIVERY SYSTEM; GENE DOSAGE; GENE EXPRESSION; GENE SEQUENCE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; BLOTTING, WESTERN; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MALE; MICROVESSELS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PHOSPHOPYRUVATE HYDRATASE; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79551662948     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.205     Document Type: Article

References (33)

1. Su H, Lu R, Kan YW. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc Natl Acad Sci USA 2000; 97: 13801-6.
2. Fitter S, Tetaz TJ, Berndt MC, Ashman LK. Molecular cloning of Cdna encoding a novel platelet-endothelial cell tetra-span antigen, PETA-3. Blood 1995; 86: 1348-55.
3. Hasegawa H, Utsunomiya Y, Kishimoto K, Yanagisawa K, Fujita S. SFA- 1, a novel cellular gene induced b human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamily. J Virol 1996; 70: 3258-63. (Pubitemid 26121946)
4. Sincock PM, Fitter S, Parton RG, Berndt MC, Gamble JR, Ashman LK. PETA-3/CD151, a member of the transmembrane 4 superfamily, is localised to the plasma membrane and endocytic system of endothelial cells, associates with multiple integrins and modulates cell function. J Cell Sci 1999; 112: 833-44.
5. Zhang XA, Bontrager AL, Hemler ME. Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins. J Biol Chem 2001; 276: 25005-13.
6. Sincock PM, Mayrhofer G, Ashman LK. Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and alpha5beta1 integrin. J Histochem Cytochem 1997; 45: 515-25.
7. Lan RF, Liu ZX, Liu XC, Song YE, Wang DW. CD151 promotes neovascularization and improves blood perfusion in a rat hind-limb ischemia model. J Endovasc Ther 2005; 12: 469-78.
8. Zheng Z, Liu Z. CD151 gene delivery activates PI3K/Akt pathway and promotes neovascularization after myocardial infarction in rats. Mol Med 2006; 12: 214-20.
9. Zuo HJ, Liu ZX, Liu XC, Yang J, Liu T, Wen S, et al. Assessment of myocardial blood perfusion improved by CD151 in a pig myocardial infarction model. Acta Pharmacol Sin 2009; 30: 70-7.
10. Zuo H, Liu Z, Liu X, Yang J, Liu T, Wen S, et al. CD151 gene delivery after myocardial infarction promotes functional neovascularization and activates FAK signaling. Mol Med 2009; 15: 307-15.
11. Schwarz ER, Speakman MT, Patterson M, Hale SS, Isner JM, Kedes LH, et al. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat - angiogenesis and angioma formation. J Am Coll Cardiol 2000; 35: 1323-30.
12. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000; 102: 898-901.
13. Su H, Kan YW. Adeno-associated viral vector-delivered hypoxiainducible gene expression in ischemic hearts. Methods Mol Biol 2007; 366: 331-42.
14. Su H, Arakawa-Hoyt J, Kan YW. Adeno-associated viral vectormediated hypoxia response element-regulated gene expression in mouse ischemic heart model. Proc Natl Acad Sci USA 2002; 99: 9480-5.
15. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996; 271: 32529-37.
16. Gupta M, Mungai PT, Goldwasser E. A new transacting factor that modulates hypoxia-induced expression of the erythropoietin gene. Blood 2000; 96: 491-7.
17. Koshikawa N, Takenaga K, Tagawa M, Sakiyama S. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells. Cancer Res 2000; 60: 2936-41.
18. Ruan H, Su H, Hu L, Lamborn KR, Kan YW, Deen DF. A hypoxiaregulated adeno-associated virus vector for cancer-specific gene therapy. Neoplasia 2001; 3: 255-63.
19. Lan R, Liu Z, Song Y, Zhang X. Effects of rAAV-CD151 and rAAVantiCD151 on the migration of human tongue squamous carcinoma cell line Tca8113. J Huazhong Univ Sci Tech Med Sci 2004; 24: 556-9.
20. Phillips MI, Tang Y, Schmidt-Ott K, Qian K, Kagiyama S. Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection. Hypertension 2002; 39: 651-5.
21. Xia JL, Dai C, Michalopoulos GK, Liu Y. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 2006; 168: 1500-12.
22. Deng X, Szabo S, Khomenko T, Jadus MR, Yoshida M. Gene therapy with adenoviral plasmids or naked DNA of vascular endothelial growth factor and platelet-derived growth factor accelerates healing of duodenal ulcer in rats. J Pharmacol Exp Ther 2004; 311: 982-8.
23. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the omparative C(T) method. Nat Protoc 2008; 3: 1101-8.
24. Yla-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000; 355: 213-22.
25. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 2002; 105: 788-93.
26. Sung HK, Kim YW, Choi SJ, Kim JY, Jeune KH, Won KC, et al. COMPangiopoietin- 1 enhances skeletal muscle blood flow and insulin sensitivity in mice. Am J Physiol Endocrinol Metab 2009; 297: E402- 409.
27. Zhang XA, Kazarov AR, Yang X, Bontrager AL, Stipp CS, Hemler ME. Function of the tetraspanin CD151-alpha6beta1 integrin complex during cellular morphogenesis. Mol Biol Cell 2002; 13: 1-11.
28. Takeda Y, Kazarov AR, Butterfield CE, Hopkins BD, Benjamin LE, Kaipainen A, et al. Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 2007; 109: 1524-32.
29. Zheng ZZ, Liu ZX. Activation of the phosphatidylinositol 3-kinase/ protein kinase Akt pathway mediates CD151-induced endothelial cell proliferation and cell migration. Int J Biochem Cell Biol 2007; 39: 340-8.
30. Shen F, Su H, Fan Y, Chen Y, Zhu Y, Liu W, et al. Adeno-associated viral-vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice. Stroke 2006; 37: 2601-6.
31. Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999; 5: 1359-64.
32. Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 2000; 80: 99-115.
33. Shen F, Fan Y, Su H, Zhu Y, Chen Y, Liu W, et al. Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice. Gene Ther 2008; 15: 30-9.